Lars Olson
Affiliations: | Karolinska Institute, Stockholm, Sweden |
Google:
"Lars Olson"Mean distance: 15.34 (cluster 11)
Children
Sign in to add trainee| Ann-Charlotte Granholm | grad student | MUSC | |
| Ingrid Stromberg | grad student | Karolinska | |
| Elliot James Glotfelty | grad student | 2017- | Karolinska |
| Andrea Carmine Belin | grad student | 1999-2003 | Karolinska |
| Jaime M. Ross | grad student | 2006-2012 | Karolinska Institutet - NIDA |
| Jacob Kjell | grad student | 2010-2014 | Karolinska |
| Daniel Goldowitz | post-doc | ||
| Jaime M. Ross | post-doc | 2013- | Karolinska |
Collaborators
Sign in to add collaborator
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen YH, Kuo TT, Wang V, et al. (2024) Serotonergic Regulation of Synaptic Dopamine Levels Mitigates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease. Journal of Parkinson's Disease |
| Wang V, Tseng KY, Kuo TT, et al. (2024) Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice. Journal of Biomedical Science. 31: 38 |
| Ross JM, Olson L, Coppotelli G. (2024) Mitochondrial Dysfunction and Protein Homeostasis in Aging: Insights from a Premature-Aging Mouse Model. Biomolecules. 14 |
| Glotfelty EJ, Tovar-Y-Romo LB, Hsueh SC, et al. (2023) The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia. Cells. 12 |
| Glotfelty EJ, Hsueh SC, Claybourne Q, et al. (2023) Microglial Nogo delays recovery following traumatic brain injury in mice. Glia |
| Kuo TT, Chen YH, Wang V, et al. (2023) PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease. International Journal of Molecular Sciences. 24 |
| Tseng KY, Kuo TT, Wang V, et al. (2022) Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease. Journal of Parkinson's Disease |
| Wang V, Kuo TT, Huang EY, et al. (2021) Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease. Acs Pharmacology & Translational Science. 4: 858-869 |
| Glotfelty EJ, Olson L, Karlsson TE, et al. (2020) Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease. Expert Opinion On Investigational Drugs. 1-8 |
| Chen YH, Wang V, Huang EY, et al. (2019) Delayed Dopamine Dysfunction and Motor Deficits in Female Parkinson Model Mice. International Journal of Molecular Sciences. 20 |